ETOLOCE Trademark

Trademark Overview


On Wednesday, October 25, 2023, a trademark application was filed for ETOLOCE with the United States Patent and Trademark Office. The USPTO has given the ETOLOCE trademark a serial number of 98240030. The federal status of this trademark filing is REGISTERED as of Tuesday, January 7, 2025. This trademark is owned by Samsung Bioepis Co., Ltd.. The ETOLOCE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for medical use, namely, pharmaceutical preparations for immunoregulation, for treatment of autoimmune diseases, for use as anti-cancer agents, for treatment of cancer, for treatment of tumors, for treatment of central nervous system disorders and for treatment of metabolic diseases; pharmaceutical preparations for the treatment of immune system related diseases; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of psoriatic arthritis; pharmaceutical preparations for the treatment of ankylosing spondylitis; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of polyarticular juvenile idiopathic arthritis; pharmaceutical preparations for the treatment of enthesitis-related arthritis
etoloce

General Information


Serial Number98240030
Word MarkETOLOCE
Filing DateWednesday, October 25, 2023
Status700 - REGISTERED
Status DateTuesday, January 7, 2025
Registration Number7638977
Registration DateTuesday, January 7, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 17, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for medical use, namely, pharmaceutical preparations for immunoregulation, for treatment of autoimmune diseases, for use as anti-cancer agents, for treatment of cancer, for treatment of tumors, for treatment of central nervous system disorders and for treatment of metabolic diseases; pharmaceutical preparations for the treatment of immune system related diseases; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of psoriatic arthritis; pharmaceutical preparations for the treatment of ankylosing spondylitis; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of polyarticular juvenile idiopathic arthritis; pharmaceutical preparations for the treatment of enthesitis-related arthritis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 31, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSamsung Bioepis Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressYeonsu-gu, Incheon 21987
KR

Party NameSamsung Bioepis Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressYeonsu-gu, Incheon 21987
KR

Party NameSamsung Bioepis Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressYeonsu-gu, Incheon 21987
KR

Trademark Events


Event DateEvent Description
Tuesday, October 31, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 7, 2024ASSIGNED TO EXAMINER
Saturday, October 28, 2023NEW APPLICATION ENTERED
Sunday, June 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, June 16, 2024NON-FINAL ACTION E-MAILED
Sunday, June 16, 2024NON-FINAL ACTION WRITTEN
Wednesday, August 14, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 14, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 14, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 15, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 17, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 17, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 7, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, January 7, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED